Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate 2.5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate 1% lotion BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate 25mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Naphazoline hydrochloride + polyvinyl alcohol + zinc sulfate 0.02%wv/0.25%wv/0.25%wv drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc Sulfate 500micromol/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate monohydrate (substance) |
Is a |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Product containing zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate+epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate 500micromole/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Product containing lithium succinate and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate heptahydrate (substance) |
Is a |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Product containing zinc sulfate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Zinc sulfate heptahydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|
Adrenaline- and zinc sulfate-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate 2.5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate 2.5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing only zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing epinephrine and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing only lithium succinate and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Adrenaline and zinc sulfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing only epinephrine and zinc sulfate in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing only zinc sulfate in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing only zinc sulfate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Naphazoline- and polyvinyl alcohol- and zinc sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely zinc (as zinc sulfate) 45 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
1 |
Zinc sulfate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Zinc sulfate (substance) |
Inferred relationship |
Some |
|